Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Compass Pathways announced the first-ever U.S. Treatment-Resistant Depression (TRD) Awareness Day, amplified by NAMI, Mental Health America and DBSA. The release cites survey data showing nearly 95% of TRD patients describe themselves as struggling or barely getting by, with an estimated 4 million U.S. TRD patients, fewer than 5% of whom are on a TRD-indicated treatment.
Key figures
- Us trd patients estimated
- approximately 4 million
- Trd patients on indicated treatment
- fewer than 5%
- Patients functioning but struggling or worse
- nearly 95%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.